Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01399619
Brief Title: Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

First Submitted : July 20, 2011
First Submitted that Met QC Criteria : July 21, 2011
First Posted : July 22, 2011 (Estimate)

Results First Submitted : July 3, 2015
Results First Submitted that Met QC Criteria : August 6, 2015
Results First Posted : September 4, 2015 (Estimate)

Certification/Extension First Submitted : June 2, 2014
Certification/Extension First Submitted that Met QC Criteria : June 2, 2014
Certification/Extension First Posted : June 17, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : July 28, 2016
Last Update Posted : August 29, 2016 (Estimate)